Northwest Biotherapeutics (NWBO) Convertible Debt (2010 - 2026)
Northwest Biotherapeutics (NWBO) reported Convertible Debt of $3.84 million for Q2 2026, down 72.1% from $13.77 million a year earlier and down 48.9% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Convertible Debt (2010 - 2026) Analysis & Trends
At the end of FY2025, Northwest Biotherapeutics posted Convertible Debt of $5.22 million, down 67.2% from FY2024.
- Convertible Debt has a five-year compound annual growth rate of 77.1% (FY2020 to FY2025).
- By year, Convertible Debt came in at $15.9 million in FY2024 and $300,000 in FY2021 (unchanged).
- The Q2 2026 figure ranks as the lowest quarterly Convertible Debt since Q3 2024.
- Year over year, Convertible Debt has now declined in each of the last three quarters, with growth averaging 92.7% over the last four quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.51 million (Q1 2026), $5.22 million (Q4 2025) and $24.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.64 Bn | 1,139.22 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 640.54 Bn | 559.06 Bn | 17.26 Bn |
| 3 | AbbVie | 501.78 Bn | 474.89 Bn | 12.70 Bn |
| 4 | Merck | 374.95 Bn | 329.32 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.43 Bn | 266.42 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.31 Bn | 241.99 Bn | 12.86 Bn |
| 7 | Amgen | 242.70 Bn | 198.10 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.64 Bn | 167.84 Bn | 6.22 Bn |
| 9 | Pfizer | 172.34 Bn | 118.98 Bn | 10.94 Bn |
| 10 | Northwest Biotherapeutics | 250.47 Mn | 240.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.84 Mn |
| Mar 31, 2026 | 7.51 Mn |
| Dec 31, 2025 | 5.22 Mn |
| Sep 30, 2025 | 24.62 Mn |
| Jun 30, 2025 | 13.77 Mn |
| Mar 31, 2025 | 13.04 Mn |
| Dec 31, 2024 | 15.90 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2020 | 300,000.00 |
| Sep 30, 2020 | 315,000.00 |
| Jun 30, 2020 | 315,000.00 |
| Mar 31, 2020 | 240,000.00 |
| Sep 30, 2018 | 5.19 Mn |
| Jun 30, 2018 | 6.47 Mn |
| Mar 31, 2018 | 6.55 Mn |
| Dec 31, 2017 | 6.01 Mn |
| Sep 30, 2017 | 5.07 Mn |
| Jun 30, 2017 | 5.38 Mn |
| Jun 30, 2016 | 10.68 Mn |
API Access
Northwest Biotherapeutics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();